Stay updated with breaking news from Synaptogenix Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synaptogenix, Inc. (NASDAQ:SNPX – Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 33,700 shares, a growth of 183.2% from the March 31st total of 11,900 shares. Based on an average daily trading volume, of 48,500 shares, the short-interest ratio is currently 0.7 […]
NEW YORK, April 24, 2024 /PRNewswire/ -- Synaptogenix, Inc. , an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that it received notice...
Synaptogenix shares are trading lower Thursday morning. The company announced a 1-for-25 reverse stock split.
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.
